<DOC>
	<DOCNO>NCT00142506</DOCNO>
	<brief_summary>Radiation sometimes affect ability person normal erection . Complete loss erection radiation treatment happen 40-50 % treated patient . There medication , like sildenafil ( also know Viagra ) , help ability get back erection almost 70 % patient . The purpose study see take Viagra every day start right , 6 month treatment , could reduce risk long-term erectile dysfunction .</brief_summary>
	<brief_title>Study Sildenafil Citrate During After Radiotherapy/Hormone Therapy Erectile Function Versus Radiotherapy/Hormone Therapy Prostate Cancer</brief_title>
	<detailed_description>This protocol randomize prospective study compare prophylactic demand Sildenafil Citrate usage administer radiotherapy combination without hormone therapy versus radiotherapy alone preservation erectile function potent patient clinically localized prostate cancer . The primary objective protocol determine prophylactic demand usage Sildenafil Citrate preserve spontaneous erectile function well diminish time restoration erectile function potent men receive radiotherapy without hormone therapy localize prostate cancer . Secondary objective study : determine whether prophylactic demand use Sildenafil Citrate therapy may improve long-term response drug follow treatment ; determine whether prophylactic demand use Sildenafil Citrate therapy reduce acute late urinary effect radiotherapy ; determine impact dosimetry radiation exposure neurovascular bundle bulb penis erectile function preservation study population undergo brachytherapy hormone therapy ; ass impact quality life follow prophylactic demand Sildenafil Citrate usage study population ; determine relationship testosterone level , erectile function efficacy prophylactic demand Sildenafil Citrate usage study population .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>To receive external beam radiation therapy and/or brachytherapy biopsyproven prostate cancer . Baseline International Index Erectile Function ( IIEF ) erectile function domain score &gt; = 17 . Patients receive radiotherapy hormone therapy undergo maximum 9 month hormone therapy acceptable . Baseline IIEFEF ( 130 ) domain score &lt; 17 pretherapy Current routine use erectogenic agent ( use agent &gt; 4 time per month would constitute `` routine use '' ) Neoadjuvant androgen deprivation therapy start 1 month prior entry study ( intake Bicalutamide alone constitute exclusion study entry ) Have clinically significant penile deformity opinion investigator ( ie : Peyronie 's Disease ) Nonorgan confine disease Prior prostate surgery cryotherapy Prior prostate radiotherapy start 2 week prior entry study Currently take 0.8mg Flomax daily Penile implant history Present baseline chronic angina require nitrate , angina occur sexual intercourse unstable angina within last 6 month . History myocardial infarction , coronary artery bypass graft surgery percutaneous coronary intervention within 90 day baseline visit . History significant cardiac conduction defect within 90 day baseline visit . Exhibit systolic blood pressure &gt; 170 &lt; 90 mm Hg diastolic blood pressure &gt; 100 &lt; 50 mm Hg baseline visit history malignant hypertension Have condition would interfere subject 's ability provide inform consent comply study instruction , would place subject increase risk , might confound interpretation study result Currently receive treatment nitrate , cancer chemotherapy , antiandrogens ( except finasteride take Propecia Proscar ) Have history drug , alcohol , substance abuse within past 6 month , assess investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Cancer Prostate</keyword>
	<keyword>Prostate Neoplasms</keyword>
	<keyword>Prostatic Cancer</keyword>
	<keyword>Viagra</keyword>
	<keyword>05-007</keyword>
</DOC>